Biosimilars Market Size, Share & Trends Analysis By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins), By Application (Rheumatoid Arthritis, Oncology), By Region And Segment Forecasts 2023 - 2030

Table of Contents

Chapter 1. Biosimilars Market: Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Product
                       1.1.2. Application
                       1.1.3. Regional scope
                       1.1.4. Estimates and forecast timeline.
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Biosimilars Market: Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                       2.2.2. Application outlook
                       2.2.3. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Biosimilars Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook.
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Industry Value Chain Analysis
                       3.3.1. Reimbursement framework
                   3.4. Market Dynamics
                       3.4.1. Market driver analysis
                           3.4.1.1. Increasing emphasis on cutting down healthcare expenditure
                           3.4.1.2. Cost-effectiveness of biosimilar drugs
                           3.4.1.3. Positive outcome in the ongoing clinical trials
                           3.4.1.4. R&D investments are increasing.
                           3.4.1.5. Patent expiration of biologics to boost the biosimilars market
                       3.4.2. Market restraint analysis
                           3.4.2.1. High manufacturing complexities and costs
                           3.4.2.2. Presence of non-original biologics and biobetters
                   3.5. Biosimilars Market Analysis Tools
                       3.5.1. Industry Analysis - Porter’s
                           3.5.1.1. Supplier power
                           3.5.1.2. Buyer power
                           3.5.1.3. Substitution threat
                           3.5.1.4. Threat of new entrant
                           3.5.1.5. Competitive rivalry
                       3.5.2. PESTEL Analysis
                           3.5.2.1. Political landscape
                           3.5.2.2. Technological landscape
                           3.5.2.3. Economic landscape
Chapter 4. Biosimilars Market: Product Estimates & Trend Analysis
                   4.1. Biosimilars Market: Key Takeaways
                   4.2. Biosimilars Market: Movement & Market Share Analysis, 2022 & 2030
                   4.3. Recombinant Non-glycosylated Proteins
                       4.3.1. Recombinant non-glycosylated proteins market estimates and forecasts, 2018 to 2030 (USD Billion)
                       4.3.2. Human growth hormone
                           4.3.2.1. Human growth hormone market estimates and forecasts, 2018 to 2030 (USD Billion)
                       4.3.3. Granulocyte colony-stimulating factor
                           4.3.3.1. Granulocyte colony-stimulating factor market estimates and forecasts, 2018 to 2030 (USD Billion)
                       4.3.4. Interferons
                           4.3.4.1. Interferons market estimates and forecasts, 2018 to 2030 (USD Billion)
                       4.3.5. Insulin
                           4.3.5.1. Insulin market estimates and forecasts, 2018 to 2030 (USD Billion)
                   4.4. Recombinant Glycosylated Proteins
                       4.4.1. Recombinant glycosylated proteins market estimates and forecasts, 2018 to 2030 (USD Billion)
                       4.4.2. Erythropoietin
                           4.4.2.1. Erythropoietin market estimates and forecasts, 2018 to 2030 (USD Billion)
                       4.4.3. Monoclonal antibodies
                           4.4.3.1. Monoclonal antibodies market estimates and forecasts, 2018 to 2030 (USD Billion)
                       4.4.4. Follitropin
                           4.4.4.1. Follitropin market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Biosimilars Market: Application Estimates & Trend Analysis
                   5.1. Biosimilars Market: Key Takeaways
                   5.2. Biosimilars Market: Movement & Market Share Analysis, 2022 & 2030
                   5.3. Oncology
                       5.3.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Billion)
                   5.4. Blood Disorders
                       5.4.1. Blood disorders market estimates and forecasts, 2018 to 2030 (USD Billion)
                   5.5. Growth Hormonal Deficiency
                       5.5.1. Growth hormonal deficiency market estimates and forecasts, 2018 to 2030 (USD Billion)
                   5.6. Chronic And Autoimmune Disorders
                       5.6.1. Chronic and autoimmune disorders market estimates and forecasts, 2018 to 2030 (USD Billion)
                   5.7. Others
                       5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Biosimilars Market: Regional Estimates & Trend Analysis
                   6.1. Regional Outlook
                   6.2. Biosimilars Market by Region: Key Marketplace Takeaway
                   6.3. North America
                       6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.3.2. U.S.
                           6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.3.3. Canada
                           6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                   6.4. Europe
                       6.4.1. UK
                           6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.4.2. Germany
                           6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.4.3. France
                           6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.4.4. Italy
                           6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.4.5. Spain
                           6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.4.6. Sweden
                           6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.4.7. Norway
                           6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.4.8. Denmark
                           6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                   6.5. Asia Pacific
                       6.5.1. Japan
                           6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.5.2. China
                           6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.5.3. India
                           6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.5.4. Australia
                           6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.5.5. Thailand
                           6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.5.6. South Korea
                           6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                   6.6. Latin America
                       6.6.1. Brazil
                           6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.6.2. Mexico
                           6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.6.3. Argentina
                           6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                   6.7. MEA
                       6.7.1. Saudi Arabia
                           6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.7.2. South Africa
                           6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.7.3. UAE
                           6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                       6.7.4. Kuwait
                           6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Market Participant Categorization
                       7.2.1. Amgen Inc.
                           7.2.1.1. Company overview
                           7.2.1.2. Financial performance
                           7.2.1.3. Product benchmarking
                           7.2.1.4. Strategic initiatives
                       7.2.2. F Hoffman La Roche Ltd.
                           7.2.2.1. Company overview
                           7.2.2.2. Financial performance
                           7.2.2.3. Product benchmarking
                           7.2.2.4. Strategic initiatives
                       7.2.3. Sandoz International GmbH
                           7.2.3.1. Company overview
                           7.2.3.2. Financial performance
                           7.2.3.3. Product benchmarking
                           7.2.3.4. Strategic initiatives
                       7.2.4. Dr. Reddy’s Laboratories Ltd.
                           7.2.4.1. Company overview
                           7.2.4.2. Financial performance
                           7.2.4.3. Product benchmarking
                           7.2.4.4. Strategic initiatives
                       7.2.5. Teva Pharmaceutical Industries Ltd.
                           7.2.5.1. Company overview
                           7.2.5.2. Financial performance
                           7.2.5.3. Product benchmarking
                           7.2.5.4. Strategic initiatives
                       7.2.6. Pfizer Inc.
                           7.2.6.1. Company overview
                           7.2.6.2. Financial performance
                           7.2.6.3. Product benchmarking
                           7.2.6.4. Strategic initiatives
                       7.2.7. Samsung Biopis
                           7.2.7.1. Company overview
                           7.2.7.2. Financial performance
                           7.2.7.3. Product benchmarking
                           7.2.7.4. Strategic initiatives
                       7.2.8. Biocon
                           7.2.8.1. Company overview
                           7.2.8.2. Financial performance
                           7.2.8.3. Product benchmarking
                           7.2.8.4. Strategic initiatives
                       7.2.9. Viatris Inc.
                           7.2.9.1. Company overview
                           7.2.9.2. Financial performance
                           7.2.9.3. Product benchmarking
                           7.2.9.4. Strategic initiatives
                       7.2.10. Celltrion Healthcare Co., Ltd
                           7.2.10.1. Company overview
                           7.2.10.2. Financial performance
                           7.2.10.3. Product benchmarking
                           7.2.10.4. Strategic initiatives
                       7.2.11. AbbVie Inc.
                           7.2.11.1. Company overview
                           7.2.11.2. Financial performance
                           7.2.11.3. Product benchmarking
                           7.2.11.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 3 North America biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 4 North America biosimilars market, by region, 2018 - 2030 (USD Billion)
Table 5 U.S. biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 6 U.S. biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 7 Canada biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 8 Canada biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 9 Europe biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 10 Europe biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 11 Europe biosimilars market, by region, 2018 - 2030 (USD Billion)
Table 12 Germany biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 13 Germany biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 14 UK biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 15 UK biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 16 France biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 17 France biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 18 Italy biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 19 Italy biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 20 Spain biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 21 Spain biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 22 Sweden biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 23 Sweden biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 24 Norway biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 25 Norway biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 26 Denmark biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 27 Denmark biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 28 Asia Pacific biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 29 Asia Pacific biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 30 Asia Pacific biosimilars market, by region, 2018 - 2030 (USD Billion)
Table 31 China biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 32 China biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 33 Japan biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 34 Japan biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 35 India biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 36 India biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 37 Thailand biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 38 Thailand biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 39 South Korea biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 40 South Korea biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 41 Latin America biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 42 Latin America biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 43 Latin America biosimilars market, by region, 2018 - 2030 (USD Billion)
Table 44 Brazil biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 45 Brazil biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 46 Mexico biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 47 Mexico biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 48 Argentina biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 49 Argentina biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 50 Middle East and Africa biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 51 Middle East and Africa biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 52 Middle East and Africa biosimilars market, by region, 2018 - 2030 (USD Billion)
Table 53 South Africa biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 54 South Africa biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 55 Saudi Arabia biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 56 Saudi Arabia biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 57 UAE biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 58 UAE biosimilars market, by application, 2018 - 2030 (USD Billion)
Table 59 Kuwait biosimilars market, by product, 2018 - 2030 (USD Billion)
Table 60 Kuwait biosimilars market, by application, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Biosimilars market outlook
Fig. 9 Biosimilars competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Biosimilars market driver impact
Fig. 15 Biosimilars market restraint impact
Fig. 16 Biosimilars market strategic initiatives analysis
Fig. 17 Biosimilars market: Product movement analysis
Fig. 18 Biosimilars market: Product outlook and key takeaways
Fig. 19 Recombinant non-glycosylated proteins market estimates and forecasts, 2018 - 2030
Fig. 20 Recombinant glycosylated proteins market estimates and forecasts, 2018 - 2030
Fig. 21 Biosimilars market: Application movement analysis
Fig. 22 Biosimilars market: Application outlook and key takeaways
Fig. 23 Oncology market estimates and forecasts, 2018 - 2030
Fig. 24 Blood disorders market estimates and forecasts, 2018 - 2030
Fig. 25 Growth hormonal deficiency market estimates and forecasts, 2018 - 2030
Fig. 26 Rheumatoid arthritis market estimates and forecasts, 2018 - 2030
Fig. 27 Chronic and autoimmune disorders market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 Global biosimilars market: Regional movement analysis
Fig. 30 Global biosimilars market: Regional outlook and key takeaways
Fig. 31 North America market estimates and forecasts, 2018 - 2030
Fig. 32 U.S. market estimates and forecasts, 2018 - 2030
Fig. 33 Canada market estimates and forecasts, 2018 - 2030
Fig. 34 Europe. market estimates and forecasts, 2018 - 2030
Fig. 35 UK market estimates and forecasts, 2018 - 2030
Fig. 36 Germany market estimates and forecasts, 2018 - 2030
Fig. 37 France market estimates and forecasts, 2018 - 2030
Fig. 38 Italy market estimates and forecasts, 2018 - 2030
Fig. 39 Spain market estimates and forecasts, 2018 - 2030
Fig. 40 Sweden market estimates and forecasts, 2018 - 2030
Fig. 41 Norway market estimates and forecasts, 2018 - 2030
Fig. 42 Denmark market estimates and forecasts, 2018 - 2030
Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 44 Japan market estimates and forecasts, 2018 - 2030
Fig. 45 China market estimates and forecasts, 2018 - 2030
Fig. 46 India market estimates and forecasts, 2018 - 2030
Fig. 47 Australia market estimates and forecasts, 2018 - 2030
Fig. 48 Thailand market estimates and forecasts, 2018 - 2030
Fig. 49 South Korea market estimates and forecasts, 2018 - 2030
Fig. 50 Latin America market estimates and forecasts, 2018 - 2030
Fig. 51 Brazil market estimates and forecasts, 2018 - 2030
Fig. 52 Mexico market estimates and forecasts, 2018 - 2030
Fig. 53 Argentina market estimates and forecasts, 2018 - 2030
Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 56 South Africa market estimates and forecasts, 2018 - 2030
Fig. 57 UAE market estimates and forecasts, 2018 - 2030
Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030